CliffBio
small molecule

CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER

CIPROFLOXACIN

Loss of exclusivity—loss of exclusivity
CompanyINFORLIFE SA

Drug detail

Brand nameCIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Active ingredientCIPROFLOXACIN
Strength400MG/200ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalMarch 2008
Marketing statusRX

More from INFORLIFE SA

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER patent cliff — loss of exclusivity — | CliffBio